Connor, Clark & Lunn Investment Management (CC&L)’s Madrigal Pharmaceuticals MDGL Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $30.3M | Sell |
100,095
-2,265
| -2% | -$685K | 0.11% | 171 |
|
2025
Q1 | $33.9M | Sell |
102,360
-928
| -0.9% | -$307K | 0.15% | 120 |
|
2024
Q4 | $31.9M | Buy |
103,288
+31,205
| +43% | +$9.63M | 0.14% | 116 |
|
2024
Q3 | $15.3M | Sell |
72,083
-10,979
| -13% | -$2.33M | 0.07% | 203 |
|
2024
Q2 | $23.3M | Sell |
83,062
-10,535
| -11% | -$2.95M | 0.1% | 168 |
|
2024
Q1 | $25M | Buy |
93,597
+39,490
| +73% | +$10.5M | 0.11% | 170 |
|
2023
Q4 | $12.5M | Buy |
54,107
+2,421
| +5% | +$560K | 0.06% | 246 |
|
2023
Q3 | $7.55M | Sell |
51,686
-14,075
| -21% | -$2.06M | 0.04% | 297 |
|
2023
Q2 | $15.2M | Sell |
65,761
-2,903
| -4% | -$671K | 0.08% | 196 |
|
2023
Q1 | $16.6M | Buy |
68,664
+8,257
| +14% | +$2M | 0.09% | 178 |
|
2022
Q4 | $17.5M | Buy |
60,407
+35,418
| +142% | +$10.3M | 0.1% | 158 |
|
2022
Q3 | $1.62M | Buy |
24,989
+18,264
| +272% | +$1.19M | 0.01% | 538 |
|
2022
Q2 | $481K | Buy |
6,725
+3,376
| +101% | +$241K | ﹤0.01% | 791 |
|
2022
Q1 | $329K | Sell |
3,349
-1,096
| -25% | -$108K | ﹤0.01% | 856 |
|
2021
Q4 | $377K | Buy |
4,445
+1,871
| +73% | +$159K | ﹤0.01% | 858 |
|
2021
Q3 | $205K | Buy |
+2,574
| New | +$205K | ﹤0.01% | 944 |
|
2019
Q1 | – | Sell |
-6,650
| Closed | -$750K | – | 996 |
|
2018
Q4 | $750K | Sell |
6,650
-1,800
| -21% | -$203K | 0.01% | 613 |
|
2018
Q3 | $1.81M | Buy |
+8,450
| New | +$1.81M | 0.01% | 456 |
|
2016
Q3 | – | Sell |
-376,200
| Closed | -$98K | – | 887 |
|
2016
Q2 | $98K | Hold |
376,200
| – | – | ﹤0.01% | 804 |
|
2016
Q1 | $90K | Hold |
376,200
| – | – | ﹤0.01% | 772 |
|
2015
Q4 | $132K | Buy |
376,200
+140,600
| +60% | +$49.3K | ﹤0.01% | 734 |
|
2015
Q3 | $410K | Buy |
235,600
+130,400
| +124% | +$227K | ﹤0.01% | 555 |
|
2015
Q2 | $235K | Sell |
105,200
-14,900
| -12% | -$33.2K | ﹤0.01% | 532 |
|
2015
Q1 | $233K | Hold |
120,100
| – | – | ﹤0.01% | 484 |
|
2014
Q4 | $318K | Buy |
120,100
+31,000
| +35% | +$82K | ﹤0.01% | 453 |
|
2014
Q3 | $268K | Buy |
+89,100
| New | +$268K | ﹤0.01% | 463 |
|